RESUMEN
BACKGROUND: The human activation peptide of factor XIII (AP-FXIII) comprises the first 37 amino acids of the N-terminus and holds the FXIII in an inactive state. FXIII is activated either proteolytically by cleavage of AP-FXIII by thrombin, or non-proteolytically by high calcium concentrations. OBJECTIVE: To investigate the role of AP-FXIII in the expression and stability of FXIII. METHODS: We cloned 13 FXIII variants with progressive truncations of AP-FXIII from the N-terminus (delN-FXIII-A), expressed them in mammalian cells, and measured their thermostability, activation, and transglutaminase activity. We also used in silico calculations to analyze the stability of hypothetical delN-FXIII dimers and to identify crucial motifs within AP-FXIII. RESULTS: Variants with deletions longer than the first 10 amino acids and an R11Q point mutant were not expressed as proteins. In silico calculations indicated that the sequence (8) FGGR(12) R plays a substantial role in intersubunit interactions in FXIII-A2 homodimers. In agreement with this prediction, the temperature stability of delN-FXIII variants decreased with increasing length of deletion. These results may suggest a role of the N-terminus of AP-FXIII in dimer stability. Substantial sequence homology was found among activation peptides of vertebrate and even invertebrate (crustacean) FXIII-A orthologs, which further supports our conclusion. CONCLUSIONS: We conclude that deletion of 11 or more N-terminal amino acids disrupts intersubunit interactions, which may prevent FXIII-A2 homodimer formation. Therefore, AP-FXIII plays an important role in the stability of the FXIII-A2 dimer.
Asunto(s)
Factor XIII/metabolismo , Factor XIIIa/metabolismo , Péptidos/metabolismo , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Células CHO , Cricetulus , Activación Enzimática , Estabilidad de Enzimas , Factor XIII/química , Factor XIII/genética , Factor XIIIa/química , Factor XIIIa/genética , Regulación Enzimológica de la Expresión Génica , Humanos , Péptidos y Proteínas de Señalización Intercelular , Datos de Secuencia Molecular , Mutación , Péptidos/química , Péptidos/genética , Desnaturalización Proteica , Multimerización de Proteína , Temperatura , Transfección , Transglutaminasas/metabolismoRESUMEN
Deficiency of coagulation factor XIII (FXIII) belongs to the rare bleeding disorders and its incidence is higher in populations with consanguineous marriages. The aims of this study were to characterize patients and relatives from seven families with suspected FXIII deficiency from Pakistan and to identify the underlying mutations. As a first indicator of FXIII deficiency, a 5M urea clot solubility test was used. Plasma FXIII A- and B-subunit antigen levels were determined by ELISA. FXIII activity was measured with an incorporation assay. Sequencing of all exons and intron/exon boundaries of F13A was performed, and a novel splice site defect was confirmed by RT-PCR analysis. Genetic analysis revealed six different mutations in the F13A gene. Two splice site mutations were detected, a novel c.1460+1G>A mutation in the first nucleotide of intron 11 and a previously reported c.2045G>A mutation in the last nucleotide of exon 14. Neither of them was expressed at protein level. A novel nonsense mutation in exon 4, c.567T>A, p.Cys188X, was identified, leading in homozygous form to severe FXIII deficiency. Two novel missense mutations were found in exons 8 and 9, c.1040C>A, p.Ala346Asp and c.1126T>C, p.Trp375Arg, and a previously reported missense mutation in exon 10, c.1241C>T, p.Ser413Leu. All patients homozygous for these missense mutations presented with severe FXIII deficiency. We have analysed a cohort of 27 individuals and reported four novel mutations leading to congenital FXIII deficiency.
Asunto(s)
Análisis Mutacional de ADN , Deficiencia del Factor XIII/genética , Factor XIII/genética , Mutación , Linaje , Adolescente , Adulto , Secuencia de Bases , Niño , Preescolar , Factor XIII/química , Femenino , Humanos , Masculino , Modelos Moleculares , Pakistán , Conformación Proteica , Adulto JovenRESUMEN
Coagulation factor (F)XIII is best known for its role in fibrin stabilization and cross-linking of antifibrinolytic proteins to the fibrin clot. From patients with congenital FXIII deficiency, it is known that FXIII also has important functions in wound healing and maintaining pregnancy. Over the last decade more and more research groups with different backgrounds have studied FXIII and have unveiled putative novel functions for FXIII. FXIII, with its unique role as a transglutaminase among the other serine protease coagulation factors, is now recognized as a multifunctional protein involved in regulatory mechanisms and construction and repair processes beyond hemostasis with possible implications in many areas of medicine. The aim of this review was to give an overview of exciting novel findings and to highlight the remarkable diversity of functions attributed to FXIII. Of course, more research into the underlying mechanisms and (patho-)physiological relevance of the many described functions of FXIII is needed. It will be exciting to observe future developments in this area and to see if and how these interesting findings may be translated into clinical practice in the future.
Asunto(s)
Coagulación Sanguínea , Factor XIII/metabolismo , Animales , Coagulantes/uso terapéutico , Factor XIII/química , Factor XIII/uso terapéutico , Deficiencia del Factor XIII/sangre , Deficiencia del Factor XIII/tratamiento farmacológico , Humanos , Modelos Moleculares , Conformación Proteica , Transducción de Señal , Relación Estructura-ActividadRESUMEN
von Willebrand disease (VWD) is the most common inherited bleeding disorder, but variable severity and several classification types mean that diagnosis is often not straightforward. In many countries, the assays are not readily available and/or are not well standardized. The latest methods and the basis of VWD are discussed here, together with information from the international quality assessment programme (IEQAS). Factor XIII deficiency is a rare, but important bleeding disorder, which may be missed or diagnosed late. A discussion and update on this diagnosis is considered in the final section of our review.
Asunto(s)
Técnicas de Laboratorio Clínico/normas , Deficiencia del Factor XIII/diagnóstico , Enfermedades de von Willebrand/diagnóstico , Colágeno , Hemaglutininas , Hemofilia A/diagnóstico , Humanos , Agregación Plaquetaria , Control de Calidad , Ristocetina , Factor de von Willebrand/metabolismoAsunto(s)
Aborto Habitual/sangre , Factor XIII/análisis , Aborto Habitual/etiología , Biomarcadores/sangre , Estudios de Casos y Controles , Distribución de Chi-Cuadrado , Regulación hacia Abajo , Femenino , Francia , Humanos , Modelos Logísticos , Oportunidad Relativa , Embarazo , Medición de Riesgo , Factores de Riesgo , SuizaAsunto(s)
Coagulación Sanguínea , Deficiencia del Factor XIII/diagnóstico , Factor XIII/análisis , Algoritmos , Autoanticuerpos/sangre , Biomarcadores/sangre , Coagulación Sanguínea/genética , Pruebas de Coagulación Sanguínea/normas , Análisis Mutacional de ADN/normas , Electroforesis en Gel de Poliacrilamida/normas , Factor XIII/genética , Factor XIII/inmunología , Deficiencia del Factor XIII/sangre , Deficiencia del Factor XIII/clasificación , Deficiencia del Factor XIII/genética , Deficiencia del Factor XIII/inmunología , Fibrina/metabolismo , Predisposición Genética a la Enfermedad , Humanos , Valor Predictivo de las PruebasRESUMEN
Severe factor XIII (FXIII) deficiency is a rare autosomal recessive coagulation disorder affecting one in two million individuals. The aim of the present study was to screen for and analyse F13B gene defects in the German population. A total of 150 patients presenting with suspected FXIII deficiency and one patient with severe (homozygous) FXIII deficiency were screened for mutations in F13A and F13B genes. Twenty-five individuals presented with detectable heterozygous mutations, 12 of them in the F13A gene and 13 of them in the F13B gene. We report on the genotype-phenotype correlations of the individuals showing defects in the F13B gene. Direct sequencing revealed 12 unique mutations including seven missense mutations (Cys5Arg, Ile81Asn, Leu116Phe, Val217Ile, Cys316Phe, Val401Glu, Pro428Ser), two splice site mutations (IVS2-1G>C, IVS3-1G>C), two insertions (c.1155_1158dupACTT, c.1959insT) and one in-frame deletion (c.471-473delATT). Two of the missense mutations (Cys5Arg, Cys316Phe) eliminated disulphide bonds (Cys5-Cys56, Cys316-Cys358). Another three missense mutations, (Leu116Phe, Val401Glu, Pro428Ser) were located proximal to other cysteine disulphide bonds, therefore indicating that the region in and around these disulphide bonds is prone to functionally relevant mutations in the FXIII-B subunit. The present study reports on a fairly common prevalence of F13B gene defects in the German population. The regions in and around the cysteine disulphide bonds in the FXIII-B protein may be regions prone to frequent mutations.
Asunto(s)
Deficiencia del Factor XIII/genética , Factor XIII , Mutación/genética , Análisis Mutacional de ADN , Deficiencia del Factor XIII/epidemiología , Familia , Femenino , Genotipo , Alemania/epidemiología , Humanos , Masculino , FenotipoRESUMEN
OBJECTIVE: To explore how sexual and marital trajectories are associated with HIV infection among ever-married women in rural Malawi. METHODS: Retrospective survey data and HIV biomarker data for 926 ever-married women interviewed in the Malawi Diffusion and Ideational Change Project were used. The associations between HIV infection and four key life course transitions considered individually (age at sexual debut, premarital sexual activity, entry into marriage and marital disruption by divorce or death) were examined. These transitions were then sequenced to construct trajectories that represent the variety of patterns in the data. The association between different trajectories and HIV prevalence was examined, controlling for potentially confounding factors such as age and region. RESULTS: Although each life course transition taken in isolation may be associated with HIV infection, their combined effect appeared to be conditional on the sequence in which they occurred. Although early sexual debut, not marrying one's first sexual partner and having a disrupted marriage each increased the likelihood of HIV infection, their risk was not additive. Women who both delayed sexual debut and did not marry their first partner are, once married, more likely to experience marital disruption and to be HIV-positive. Women who marry their first partner but who have sex at a young age, however, are also at considerable risk. CONCLUSIONS: These findings identify the potential of a life course perspective for understanding why some women become infected with HIV and others do not, as well as the differentials in HIV prevalence that originate from the sequence of sexual and marital transitions in one's life. The analysis suggests, however, the need for further data collection to permit a better examination of the mechanisms that account for variations in life course trajectories and thus in lifetime probabilities of HIV infection.
Asunto(s)
Infecciones por VIH/psicología , Matrimonio/psicología , Conducta Sexual/psicología , Adolescente , Adulto , Anciano , Coito , Femenino , Infecciones por VIH/epidemiología , Infecciones por VIH/transmisión , Humanos , Malaui/epidemiología , Matrimonio/estadística & datos numéricos , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Salud Rural , Conducta Sexual/estadística & datos numéricos , Parejas Sexuales , Adulto JovenRESUMEN
OBJECTIVE: To examine the acceptance of repeat population-based voluntary counselling and testing (VCT) for HIV in rural Malawi. METHODS: Behavioural and biomarker data were collected in 2004 and 2006 from approximately 3000 adult respondents. In 2004, oral swab specimens were collected and analysed using ELISA and confirmatory Western blot tests, while finger-prick rapid testing was done in 2006. We used cross-tabulations with chi(2) tests and significance tests of proportions to determine the statistical significance of differences in acceptance of VCT by year, individual characteristics and HIV risk. RESULTS: First, over 90% of respondents in each round accepted the HIV test, despite variations in testing protocols. Second, the percentage of individuals who obtained their test results significantly increased from 67% in 2004, when the results were provided in randomly selected locations several weeks after the specimens were collected, to 98% in 2006 when they were made available immediately within the home. Third, whereas there were significant variations in the sociodemographic and behavioural profiles of those who were successfully contacted for a second HIV test, this was not the case for those who accepted repeat VCT. This suggests that variations in the success of repeat testing might come from contacting the individuals rather than from accepting the test or knowing the results. CONCLUSIONS: Repeat HIV testing at home by trained healthcare workers from outside the local area, and with either saliva or blood, is almost universally acceptable in rural Malawi and, thus, likely to be acceptable in similar contexts.
Asunto(s)
Consejo/estadística & datos numéricos , Infecciones por VIH/diagnóstico , Aceptación de la Atención de Salud/estadística & datos numéricos , Servicios de Salud Rural/estadística & datos numéricos , Programas Voluntarios/estadística & datos numéricos , Adolescente , Adulto , Femenino , Infecciones por VIH/epidemiología , Conductas Relacionadas con la Salud , Humanos , Malaui/epidemiología , Masculino , Salud Rural , Enfermedades de Transmisión Sexual/epidemiología , Adulto JovenRESUMEN
Factor XIII (FXIII) deficiency is a very rare (1:2 000 000) severe autosomal recessive bleeding disorder, mostly due to mutations in the coagulation FXIII A-subunit gene. We have studied the molecular basis of FXIII deficiency in five unrelated Italian families. The coding region, intron-exon boundaries and 5'- and 3'-untranslated regions of the FXIII gene encoding the A subunit were amplified and directly sequenced. Candidate mutations were identified in all the patients. Three novel mutations occurred in three patients. These include a novel homozygous deletion of two base pairs (bp) in exon 14 (c.2002-2003 DelCT). This deletion causes a frameshift from Leu667 and the formation of a stop codon at amino acid position 681. The second patient presents a novel homozygous (c.2126 G>A) transition in exon 15, predicting a Ser708Asn in Barrel 2 domain. The third patient is compound heterozygote for two missense mutations, a previously reported Arg260His substitution, and a novel transition in exon 4 (c.560 C>T) predicting a Pro186Leu in the core domain. The remaining two patients have two previously reported mutations: a 4-bp homozygous deletion in exon 11 (c.1392-1395 Del AATT), previously reported to occur in the Vicenza Area, and a homozygous nonsense mutation in exon 8 (c.979 C>T) predicting an Arg326X in the core domain. The novel mutations occurred at amino acid residues highly conserved among different species (pig, monkey, mouse and dog) and were not detected in 110 normal alleles. Structural analysis shows that Pro186Leu mutation leads to the replacement of the rigid proline pyrrolidine ring by the larger and more flexible leucine side chain and Ser708Asn may probably disrupt the hydrogen bond with Ala291.
Asunto(s)
Deficiencia del Factor XIII/genética , Factor XIII/genética , Mutación , Codón de Terminación , Análisis Mutacional de ADN , Salud de la Familia , Mutación del Sistema de Lectura , Componentes del Gen , Homocigoto , Humanos , Italia , Mutación Missense , Subunidades de ProteínaRESUMEN
Inherited factor XIII (FXIII) deficiency is known as one of the most rare blood coagulation disorder in humans. In the present study, phenotype and genotype of eight FXIII deficient Polish patients from five unrelated families were compared. The patients presented with a severe phenotype demonstrated by a high incidence of intracerebral haemorrhages (seven of eight patients), haemarthrosis (six patients) and bleeding due to trauma (five patients). Introduction of regular substitution with FXIII concentrate prevented spontaneous bleeding in seven patients. In all patients, mutations within the F13A gene have been identified revealing four missense mutations (Arg77Cys, Arg260Cys, Ala378Pro, Gly420Ser), one nonsense mutation (Arg661X), one splice site mutation (IVS5-1 G>A) and one small deletion (c.499-512del). One homozygous large deletion involving exon 15 was detected by failure of PCR product. The corresponding mutations resulted in severely reduced FXIII activity and FXIII A-subunit antigen concentration, while FXIII B-subunit antigen remained normal or mildly decreased. Structural analysis demonstrated that the novel Ala378Pro mutation may cause a disruption of the FXIII catalytic triad leading to a non-functional protein which presumably undergoes premature degradation. In conclusion, the severe phenotype with high incidence of intracranial bleeding and haemarthrosis was in accordance with laboratory findings on FXIII and with severe molecular defects of the F13A gene.
Asunto(s)
Deficiencia del Factor XIII/genética , Factor XIII/genética , Mutación/genética , Adulto , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Linaje , Fenotipo , Polonia/etnologíaRESUMEN
Coagulation factor XIII (FXIII) has a major role in the final stage of blood coagulation, is important for wound healing and maintaining pregnancy. Severe congenital FXIII deficiency is a rare disorder with 1 patient in 1-3 million. Untreated, it causes bleeding events, with intracranial haemorrhage being the major cause of death, impaired wound healing, and abortion. FXIII deficiency was traditionally diagnosed using the clot solubility test, but quantitative FXIII activity and antigen assays are preferred today. Treatment consists of replacement therapy with FXIII concentrates administered every 4-6 weeks. The molecular-genetic causes of FXIII deficiency are mutations in the genes coding for the FXIII A- and B-subunits. More than 60 mutations distributed throughout the FXIII A-subunit gene have been identified so far and 4 mutations in the FXIII B-subunit gene. The first case of congenital FXIII deficiency was reported in Switzerland in 1960. In Switzerland we observed a disproportionately high incidence, which can be explained in part by a founder effect. In this article, we summarise general facts on severe congenital FXIII deficiency, and we characterise all FXIII deficient patients living in Switzerland, including the first case described in 1960 who is a member of a large family originating from the canton of Uri.
Asunto(s)
Deficiencia del Factor XIII , Niño , Factor XIII/uso terapéutico , Deficiencia del Factor XIII/congénito , Deficiencia del Factor XIII/diagnóstico , Deficiencia del Factor XIII/epidemiología , Deficiencia del Factor XIII/genética , Deficiencia del Factor XIII/terapia , Hemorragia/congénito , Humanos , Incidencia , Masculino , Suiza/epidemiologíaRESUMEN
The special chemical and biological features of beta-peptides have been investigated intensively during recent years. Many studies emphasize the restricted biodegradability and the high metabolic stability of this class of compounds. beta-Peptidyl aminopeptidases form the first family of enzymes that hydrolyze a variety of short beta-peptides and beta-amino-acid-containing peptides. All representatives of this family were isolated from Gram-negative bacteria. The substrate specificities of the peptidases vary greatly, but the enzymes have common structural properties, and a similar reaction mechanism can be expected. This review gives an overview on the beta-peptidyl aminopeptidases with emphasis on their biochemical and structural properties. Their possible physiological function is discussed. Functionally and structurally related enzymes are compared to the beta-peptidyl aminopeptidases.
Asunto(s)
Aminopeptidasas/metabolismo , Péptidos/metabolismo , Proteobacteria/metabolismo , Aminoácidos/química , Aminoácidos/metabolismo , Aminopeptidasas/química , Hidrólisis , Estructura Molecular , Péptidos/químicaRESUMEN
Few diagnostic decisions in medicine have been more heavily researched and debated than the approach to patients with acute chest pain. In addition, the question is which patients with acute chest pain have a presentation benign enough to make discharge from the emergency department safe and appropriate despite the advances in diagnostic tests. There is always the possibility of missed diagnosis which may cause substantial morbidity and mortality. The use of algorithms or protocols is not always sufficient to avoid missed diagnosis and the individual physicians's diagnostic performance and clinical experience is as important as the best algorithm for atypical chest pain! Patients with atypical symptoms are most likely to be mistakenly discharged. This article does mainly focus on diagnostic tests including ECG and biomarkers such as troponin and D-dimer as well as the investigation by helical CT scan in patients with suspected pulmonary embolism. The article also discuss the importance of repeated assessments of biomarkers and the determination of the exact time interval between the first clinical symptoms and the presentation to the emergency department. This time interval can be very crucial for the diagnostic work-up of patients with acute chest pain.
Asunto(s)
Dolor en el Pecho/diagnóstico , Dolor en el Pecho/terapia , Cuidados Críticos/métodos , Servicios Médicos de Urgencia/métodos , Dimensión del Dolor/métodos , Enfermedad Aguda , Enfermedades Cardiovasculares/complicaciones , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/terapia , Dolor en el Pecho/etiología , Técnicas de Laboratorio Clínico , Diagnóstico Diferencial , Diagnóstico por Imagen/métodos , Electrocardiografía , Urgencias Médicas , Humanos , Guías de Práctica Clínica como Asunto , Pautas de la Práctica en Medicina , SuizaRESUMEN
Intoxicated patients make up 5-10% of all patients seen at emergency departments. The management of these patients is not always simple. Many of them are seen after ingestions of relatively non-toxic substances that require minimal medical care, intentional poisoning however often requires the highest standards of medical and nursing care and therefore the admission to an emergency department is mandatory. At admission, the involved substances are often not known since some of the patients are comatose. In such cases, the information from relatives and friends can be very crucial but to get hold of these sometimes essential "hints" is not always easy. Knowledge of the specific toxic agent allows the physician to plan a rational approach to the definitive management of the intoxicated patient after the vital functions have been stabilised. In some cases, very rare intoxications but with typical clinical signs do occur (e.g scromboid fish poisoning, coprinus-syndrome), which needs special diagnostic and therapeutic steps and a great deal of clinical experience. In most cases it is preferable to contact the Poison Control Center for additional advice.
Asunto(s)
Cuidados Críticos/métodos , Evaluación Preclínica de Medicamentos/métodos , Servicios Médicos de Urgencia/métodos , Intoxicación/diagnóstico , Intoxicación/terapia , Trastornos Relacionados con Sustancias/diagnóstico , Trastornos Relacionados con Sustancias/terapia , Enfermedad Aguda , Diagnóstico Diferencial , Sobredosis de Droga/diagnóstico , Sobredosis de Droga/terapia , Urgencias Médicas , Humanos , Guías de Práctica Clínica como Asunto , Pautas de la Práctica en Medicina , SuizaAsunto(s)
Obstrucción de las Vías Aéreas/etiología , Angioedema/etiología , Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Antihipertensivos/efectos adversos , Hipersensibilidad a las Drogas/diagnóstico , Disnea/etiología , Enalapril/efectos adversos , Hidroclorotiazida/efectos adversos , Enfermedades de la Lengua/etiología , Anciano , Angioedema/complicaciones , Angioedema/diagnóstico , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Antihipertensivos/uso terapéutico , Diagnóstico Diferencial , Combinación de Medicamentos , Enalapril/uso terapéutico , Paro Cardíaco/complicaciones , Paro Cardíaco/etiología , Paro Cardíaco/rehabilitación , Humanos , Hidroclorotiazida/uso terapéutico , Masculino , Enfermedades de la Lengua/complicaciones , Enfermedades de la Lengua/diagnósticoRESUMEN
In most cases, enantiomers of chiral compounds behave differently in biochemical processes. Therefore, the effects and the environmental fate of the enantiomers of chiral pollutants need to be investigated separately. In this review, the different fates of the enantiomers of chiral phenoxyalkanoic acid herbicides, acetamides, organochlorines, and linear alkylbenzenesulfonates are discussed. The focus lies on biological degradation, which may be enantioselective, in contrast to non-biotic conversions. The data show that it is difficult to predict which enantiomer may be enriched and that accumulation of an enantiomer is dependent on the environmental system, the species, and the organ. Racemization and enantiomerization processes occur and make interpretation of the data even more complex. Enantioselective degradation implies that the enzymes involved in the conversion of such compounds are able to differentiate between the enantiomers. "Enzyme pairs" have evolved which exhibit almost identical overall folding. Only subtle differences in their active site determine their enantioselectivities. At the other extreme, there are examples of non-homologous "enzyme pairs" that have developed through convergent evolution to enantioselectively turn over the enantiomers of a chiral compound. For a better understanding of enantioselective reactions, more detailed studies of enzymes involved in enantioselective degradation need to be performed.